Óscar López

3.2k total citations
116 papers, 2.5k citations indexed

About

Óscar López is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Óscar López has authored 116 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Organic Chemistry, 51 papers in Molecular Biology and 31 papers in Pharmacology. Recurrent topics in Óscar López's work include Carbohydrate Chemistry and Synthesis (33 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Organoselenium and organotellurium chemistry (16 papers). Óscar López is often cited by papers focused on Carbohydrate Chemistry and Synthesis (33 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Organoselenium and organotellurium chemistry (16 papers). Óscar López collaborates with scholars based in Spain, Portugal and Italy. Óscar López's co-authors include José G. Fernández‐Bolaños, María Victoria Gil, Inés Maya, M. J. Arévalo, Mikael Bols, James T. Becker, José M. Padrón, Penélope Merino‐Montiel, Stephen R. Wisniewski and François Boller and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Chemical Communications.

In The Last Decade

Óscar López

108 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Óscar López Spain 25 1.4k 842 310 292 199 116 2.5k
Henryk Marona Poland 21 457 0.3× 618 0.7× 104 0.3× 246 0.8× 82 0.4× 135 1.7k
Zhe‐Shan Quan China 34 2.2k 1.6× 1.3k 1.6× 150 0.5× 400 1.4× 115 0.6× 161 3.4k
Samuel Silvestre Portugal 26 850 0.6× 1.0k 1.2× 101 0.3× 383 1.3× 62 0.3× 86 2.6k
Elżbieta Pękala Poland 24 547 0.4× 912 1.1× 72 0.2× 294 1.0× 71 0.4× 141 2.2k
Afshin Zarghi Iran 35 2.0k 1.4× 989 1.2× 155 0.5× 1.2k 4.0× 101 0.5× 213 4.2k
Vasudevan Mani Saudi Arabia 33 1.1k 0.8× 679 0.8× 51 0.2× 466 1.6× 55 0.3× 153 3.3k
Sheng‐Chu Kuo Taiwan 39 1.4k 1.0× 2.0k 2.3× 386 1.2× 579 2.0× 30 0.2× 179 4.6k
Marı́a Luisa Ferrándiz Spain 39 819 0.6× 1.8k 2.1× 220 0.7× 609 2.1× 34 0.2× 98 3.9k
Faheem Hyder Pottoo Saudi Arabia 31 307 0.2× 754 0.9× 85 0.3× 239 0.8× 90 0.5× 122 2.5k
Gerd Dannhardt Germany 27 1.6k 1.1× 736 0.9× 132 0.4× 742 2.5× 83 0.4× 138 2.8k

Countries citing papers authored by Óscar López

Since Specialization
Citations

This map shows the geographic impact of Óscar López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Óscar López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Óscar López more than expected).

Fields of papers citing papers by Óscar López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Óscar López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Óscar López. The network helps show where Óscar López may publish in the future.

Co-authorship network of co-authors of Óscar López

This figure shows the co-authorship network connecting the top 25 collaborators of Óscar López. A scholar is included among the top collaborators of Óscar López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Óscar López. Óscar López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albert, Adelin, Anuradha Sehrawat, M. Carmen Fariñas, et al.. (2025). Equivalence of Plasma and Serum for Clinical Measurement of p‐tau217: Comparative Analyses of Four Blood‐Based Assays. Journal of Neurochemistry. 169(7). e70114–e70114. 3 indexed citations
2.
Westlund, Neil, et al.. (2025). An isofagomine analogue with an amidine group in the 1,6-position. Royal Society Open Science. 12(2). 241877–241877. 1 indexed citations
3.
Gildengers, Ariel, Xuemei Zeng, Howard Aizenstein, et al.. (2025). The LATTICE Study: Design of a pilot feasibility randomized controlled trial of lithium to delay cognitive decline in mild cognitive impairment. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(2). e70112–e70112.
4.
Fernández‐Bolaños, José G., et al.. (2025). An updated patent review of acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease (2021–present). Expert Opinion on Therapeutic Patents. 36(2). 159–190.
5.
Choi, Seo‐Eun, Shubhabrata Mukherjee, Laura E. Gibbons, et al.. (2025). Beyond NACC's Uniform Data Set for cognition: the impact of additional items on measurement precision. Alzheimer s & Dementia. 21(9). e70694–e70694.
6.
Stojanov, Sofija Jovanović, Adrián Puerta, Jelena Dinić, et al.. (2024). Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases. Bioorganic Chemistry. 145. 107168–107168. 6 indexed citations
7.
Puerta, Adrián, et al.. (2024). Coumarin–azasugar–benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth. Organic & Biomolecular Chemistry. 22(17). 3425–3438. 4 indexed citations
8.
Nocentini, Alessio, Alessia Costa, Alessandro Bonardi, et al.. (2024). Enhanced Recognition Memory through Dual Modulation of Brain Carbonic Anhydrases and Cholinesterases. Journal of Medicinal Chemistry. 67(18). 16873–16898. 4 indexed citations
9.
Bonardi, Alessandro, Alessio Nocentini, Paola Gratteri, et al.. (2023). Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies. Bioorganic & Medicinal Chemistry. 94. 117467–117467. 6 indexed citations
10.
Berrino, Emanuela, Simone Carradori, Fabrizio Carta, et al.. (2023). A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration. Antioxidants. 12(12). 2044–2044. 13 indexed citations
11.
Giovannuzzi, Simone, Adrián Puerta, Miguel X. Fernandes, et al.. (2023). Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors. International Journal of Molecular Sciences. 24(11). 9401–9401. 8 indexed citations
12.
Kootar, Scherazad, Md Hamidul Huque, Ranmalee Eramudugolla, et al.. (2023). Validation of the CogDrisk Instrument as Predictive of Dementia in Four General Community-Dwelling Populations. The Journal of Prevention of Alzheimer s Disease. 10(3). 478–487. 9 indexed citations
13.
Puerta, Adrián, Alessio Nocentini, Miguel X. Fernandes, et al.. (2022). Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. International Journal of Molecular Sciences. 23(14). 7685–7685. 12 indexed citations
14.
López, Óscar, Adrián Puerta, Miguel X. Fernandes, et al.. (2022). Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 349–360. 6 indexed citations
15.
López, Óscar, Adrián Puerta, Miguel X. Fernandes, et al.. (2022). A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE). Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2395–2402. 9 indexed citations
16.
García-García, Amalia, Sara Rojas, Lorenzo Rivas‐García, et al.. (2021). A gliclazide complex based on palladium towards Alzheimer's disease: promising protective activity against Aβ-induced toxicity in C. elegans. Chemical Communications. 58(10). 1514–1517. 11 indexed citations
17.
Valente, Andreia, Ana Podolski-Renić, Nenad R. Filipović, et al.. (2021). Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resistance Updates. 58. 100778–100778. 75 indexed citations
18.
Merino‐Montiel, Penélope, Sara Montiel‐Smith, Socorro Meza‐Reyes, et al.. (2021). 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 168–177. 14 indexed citations
19.
López, Óscar, et al.. (2021). Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1658–1663. 3 indexed citations
20.
Bettoschi, Alexandre, José G. Fernández‐Bolaños, Francesco Isaia, et al.. (2017). Selenoureas for anion binding as molecular logic gates. Chemical Communications. 53(87). 11869–11872. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026